Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A global perspective on the issue of access to insulin
David Beran, María Lazo‐Porras, M. Camille, et al.
Diabetologia (2021) Vol. 64, Iss. 5, pp. 954-962
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2753-2786
Open Access | Times Cited: 1158
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 675
100 years of insulin: celebrating the past, present and future of diabetes therapy
Emily K. Sims, Alice L. J. Carr, Richard A. Oram, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1154-1164
Open Access | Times Cited: 173
Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact
Edward W. Gregg, James Buckley, Mohammed K. Ali, et al.
The Lancet (2023) Vol. 401, Iss. 10384, pp. 1302-1312
Open Access | Times Cited: 127
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
Ewerton Cousin, Bruce Bartholow Duncan, Caroline Stein, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 3, pp. 177-192
Open Access | Times Cited: 101
Global accessibility of therapeutics for diabetes mellitus
Michael Fralick, Alicia J. Jenkins, Kamlesh Khunti, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 4, pp. 199-204
Open Access | Times Cited: 79
Access to antivenoms in the developing world: A multidisciplinary analysis
Julien Potet, David Beran, Nicolas Ray, et al.
Toxicon X (2021) Vol. 12, pp. 100086-100086
Open Access | Times Cited: 67
Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis
Stavroula Kastora, Manisha Patel, Ben Carter, et al.
Endocrinology Diabetes & Metabolism (2022) Vol. 5, Iss. 3
Open Access | Times Cited: 64
ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes
Eda Cengiz, Thomas Danne, Tariq Ahmad, et al.
Pediatric Diabetes (2022) Vol. 23, Iss. 8, pp. 1277-1296
Closed Access | Times Cited: 59
Cell culture medium cycling in cultured meat: Key factors and potential strategies
Ming–Hsuan Yang, Qiong Wang, Yuyan Zhu, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 564-576
Closed Access | Times Cited: 28
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis
†
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 12, pp. 825-836
Open Access | Times Cited: 41
Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data
David Flood, Pascal Geldsetzer, Kokou Agoudavi, et al.
Diabetes Care (2022) Vol. 45, Iss. 9, pp. 1961-1970
Open Access | Times Cited: 32
The phenotype of type 1 diabetes in sub-Saharan Africa
Jean-Claude Katte, Timothy J. McDonald, Eugène Sobngwi, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 17
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Brian Godman, Mainul Haque, Trudy Leong, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 35
Insulin: evolution of insulin formulations and their application in clinical practice over 100 years
Geremia B. Bolli, Alice Cheng, David R. Owens
Acta Diabetologica (2022) Vol. 59, Iss. 9, pp. 1129-1144
Open Access | Times Cited: 25
Artificial Intelligence
Nuno Geada
Advances in finance, accounting, and economics book series (2024), pp. 226-244
Closed Access | Times Cited: 4
Human versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings (HumAn-1): protocol for a randomised controlled trial
Angela Foulds, Claire Josey, Sylvia Kehlenbrink, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e092432-e092432
Open Access
Replenish Revenue by Low‐Cost Medicines, an Institution‐Specific Action to Improve Access to High‐Cost Medicines Used for Chronic Illness in Ethiopia: Narrative Review
Mende Mensa Sorato
Health Science Reports (2025) Vol. 8, Iss. 5
Open Access
Insulin therapy development beyond 100 years
Philip Home, Roopa Mehta
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 10, pp. 695-707
Closed Access | Times Cited: 24
Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial
Stéphane Besançon, Aveni Haynes, Amagara Togo, et al.
Diabetic Medicine (2025)
Closed Access
Health care delivery model in India with relevance to diabetes care
Ashok Kumar Das, Banshi Saboo, Anuj Maheshwari, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10904-e10904
Open Access | Times Cited: 16
Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based survey
Katherine J. Souris, Elizabeth Pfiester, Axel Thieffry, et al.
Frontiers in Clinical Diabetes and Healthcare (2024) Vol. 5
Open Access | Times Cited: 3
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
Brian Godman, Mainul Haque, Santosh Kumar, et al.
Current Medical Research and Opinion (2021) Vol. 37, Iss. 9, pp. 1529-1545
Open Access | Times Cited: 20
Growing global burden of type 1 diabetes needs multitiered precision public health interventions
Jingchuan Guo, Hui Shao
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 10, pp. 688-689
Closed Access | Times Cited: 13
Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach
Mona Haji, Laoucine Kerbache, Tareq Al‐Ansari
Processes (2022) Vol. 10, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top